Xencor (XNCR) EBT Margin Growth (3y) (2016 - 2026)
Xencor (XNCR) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -254,019.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -254,019.00 |
| Dec 31, 2025 | 4,254.00 |
| Sep 30, 2025 | 8,731.00 |
| Jun 30, 2025 | 12,936.00 |
| Mar 31, 2025 | -17,761.00 |
| Dec 31, 2024 | -13,189.00 |
| Sep 30, 2024 | -6,240.00 |
| Jun 30, 2024 | -20,423.00 |
| Mar 31, 2024 | -41,575.00 |
| Dec 31, 2023 | 792.00 |
| Sep 30, 2023 | -554.00 |
| Jun 30, 2023 | 11,125.00 |
| Mar 31, 2023 | -28,333.00 |
| Dec 31, 2022 | 71,596.00 |
| Sep 30, 2022 | -6,742.00 |
| Jun 30, 2022 | -11,859.00 |
| Mar 31, 2022 | -4,216.00 |
| Dec 31, 2021 | 20,482.00 |
| Sep 30, 2021 | -21,504.00 |
| Dec 31, 2020 | -5,354.00 |